{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:58:35Z","timestamp":1790470715844,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100002027","name":"Lynne Cohen Foundation for Ovarian Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["3P30CA013148-43S3"],"award-info":[{"award-number":["3P30CA013148-43S3"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5K12HD001258-14"],"award-info":[{"award-number":["5K12HD001258-14"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U10CA180855"],"award-info":[{"award-number":["U10CA180855"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.ygyno.2019.05.031","type":"journal-article","created":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T17:55:36Z","timestamp":1560189336000},"page":"379-382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Differences in referral patterns based on race for women at high-risk for ovarian cancer in the southeast: Results from a Gynecologic Cancer Risk Assessment Clinic"],"prefix":"10.1016","volume":"154","author":[{"given":"Teresa K.L.","family":"Boitano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Barrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadhvi","family":"Batra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Gerald","family":"McGwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor B.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meagan B.","family":"Farmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee M.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Michael J.","family":"Straughn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Charles A.","family":"Leath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2019.05.031_bb0005","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"44","key":"10.1016\/j.ygyno.2019.05.031_bb0010","doi-asserted-by":"crossref","first-page":"18032","DOI":"10.1073\/pnas.1115052108","article-title":"Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing","volume":"108","author":"Walsh","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.ygyno.2019.05.031_bb0015","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/jamaoncol.2015.5495","article-title":"Inherited mutations in women with ovarian carcinoma","volume":"2","author":"Norquist","year":"2016","journal-title":"JAMA Oncol."},{"issue":"26","key":"10.1016\/j.ygyno.2019.05.031_bb0020","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1056\/NEJMoa1810858","article-title":"Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer","volume":"379","author":"Moore","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2019.05.031_bb0025","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12905-014-0150-5","article-title":"Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers","volume":"14","author":"Marchetti","year":"2014","journal-title":"BMC Womens Health"},{"issue":"10","key":"10.1016\/j.ygyno.2019.05.031_bb0030","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1158\/1055-9965.EPI-17-0290","article-title":"Recent trends in ovarian cancer incidence and relative survival in the United States by race\/ethnicity and histologic subtypes","volume":"26","author":"Park","year":"2017","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"1","key":"10.1016\/j.ygyno.2019.05.031_bb0035","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ygyno.2012.12.016","article-title":"Global ovarian cancer health disparities","volume":"129","author":"Chornokur","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2019.05.031_bb0040","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ygyno.2018.02.014","article-title":"Characteristics of African American women at high-risk for ovarian cancer in the southeast: results from a Gynecologic Cancer Risk Assessment Clinic","volume":"149","author":"Barrington","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2019.05.031_bb0045","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12687-013-0166-9","article-title":"BRCA sequencing and large rearrangement testing in young black women with breast cancer","volume":"5","author":"Pal","year":"2014","journal-title":"J Community Genet."},{"issue":"2","key":"10.1016\/j.ygyno.2019.05.031_bb0050","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/tbj.12083","article-title":"Early onset breast cancer in a registry-based sample of African-American women: BRCA mutation prevalence, and other personal and system-level clinical characteristics","volume":"19","author":"Pal","year":"2013","journal-title":"Breast J."},{"issue":"10","key":"10.1016\/j.ygyno.2019.05.031_bb0055","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1245\/s10434-013-3205-1","article-title":"Prevalence of BRCA mutations among women with triple-negative breast cancer (TNBC) in a genetic counseling cohort","volume":"20","author":"Greenup","year":"2013","journal-title":"Ann. Surg. Oncol."},{"issue":"14","key":"10.1016\/j.ygyno.2019.05.031_bb0060","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.293.14.1729","article-title":"Racial differences in the use of BRCA1\/2 testing among women with a family history of breast or ovarian cancer","volume":"293","author":"Armstrong","year":"2005","journal-title":"Jama"},{"issue":"4","key":"10.1016\/j.ygyno.2019.05.031_bb0065","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1089\/gte.2005.9.306","article-title":"Recruitment, genetic counseling, and BRCA testing for underserved women at a public hospital","volume":"9","author":"Lee","year":"2005","journal-title":"Genet. Test."},{"issue":"7","key":"10.1016\/j.ygyno.2019.05.031_bb0070","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1002\/cam4.1120","article-title":"Predictors of BRCA1\/2 genetic testing among black women with breast cancer: a population-based study","volume":"6","author":"Jones","year":"2017","journal-title":"Cancer Med."},{"issue":"12","key":"10.1016\/j.ygyno.2019.05.031_bb0075","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/cncr.21536","article-title":"BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases","volume":"104","author":"Pal","year":"2005","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2019.05.031_bb0080","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/IGC.0b013e3181dbd1a5","article-title":"Moving toward personalized medicine: treatment-focused genetic testing of women newly diagnosed with ovarian cancer","volume":"20","author":"Trainer","year":"2010","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2019.05.031_bb0085","doi-asserted-by":"crossref","first-page":"9","DOI":"10.6004\/jnccn.2017.0003","article-title":"NCCN guidelines insights: genetic\/familial high-risk assessment: breast and ovarian, version 2.2017","volume":"15","author":"Daly","year":"2017","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"1","key":"10.1016\/j.ygyno.2019.05.031_bb0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2014.09.009","article-title":"Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions","volume":"136","author":"Lancaster","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2019.05.031_bb0095","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11606-016-3943-4","article-title":"Primary care providers' cancer genetic testing-related knowledge, attitudes, and communication behaviors: a systematic review and research agenda","volume":"32","author":"Hamilton","year":"2017","journal-title":"J. Gen. Intern. Med."},{"issue":"2","key":"10.1016\/j.ygyno.2019.05.031_bb0100","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jama.296.2.185","article-title":"Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation","volume":"296","author":"Finch","year":"2006","journal-title":"Jama"},{"issue":"9","key":"10.1016\/j.ygyno.2019.05.031_bb0105","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"Jama"},{"issue":"8","key":"10.1016\/j.ygyno.2019.05.031_bb0110","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1200\/JCO.2007.13.9626","article-title":"Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study","volume":"26","author":"Kauff","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2019.05.031_bb0115","article-title":"Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations","volume":"8","author":"Eleje","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"issue":"4","key":"10.1016\/j.ygyno.2019.05.031_bb0120","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.amjsurg.2016.06.010","article-title":"Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review","volume":"212","author":"Ludwig","year":"2016","journal-title":"Am. J. Surg."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825819312752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825819312752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T09:28:33Z","timestamp":1778664513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825819312752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0090825819312752"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2019.05.031","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differences in referral patterns based on race for women at high-risk for ovarian cancer in the southeast: Results from a Gynecologic Cancer Risk Assessment Clinic","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2019.05.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}